MedTrace Logo

Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy.

NCT02033343 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-06-14

No results posted yet for this study

Summary

The purpose of this study is to monitor movement of the prostate during radiotherapy and adjust the radiation beam to account for any motion seen. This will increase the radiation dose to the prostate and decrease the dose to the rectum and bladder.

Conditions

Interventions

RADIATION

Prostate cancer radiotherapy using real-time tracking

Radiotherapy delivered using Calypso radiofrequency emitting beacon guided real-time prostate localisation and beam adjustment using Dynamic Multi-leaf Collimator tracking software.

Sponsors & Collaborators

  • University of Sydney

    collaborator OTHER

  • Royal North Shore Hospital

    lead OTHER

Principal Investigators

  • Thomas N Eade, MBBS · Royal North Shore Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02033343 on ClinicalTrials.gov